Comparison of Endotoxin Activity Assay and Various Biomarkers for Severity Assessment in Colorectal Perforation Patients

Am Surg. 2023 Jun;89(6):2854-2856. doi: 10.1177/00031348211056256. Epub 2021 Dec 17.

Abstract

Colorectal perforation is a serious disease with high mortality requiring emergency surgery. This study aimed to evaluate the role of the endotoxin activity assay (EAA) to assess the severity in patients admitted to the intensive care unit after emergency surgeries for colorectal perforations. Patients were divided into high (EAA ≥.4) and low (EAA <.4) groups based on the EAA levels, and the correlation between the EAA values and clinical variables related to the severity was evaluated. The SOFA scores were significantly higher in the high group than those in the low group. The high EAA value persisted even after 48 hours and extended the ICU length of stay. These results suggest that EAA may be a potential biomarker to assess severity and useful as one of the instrumental in predicting the outcomes for colorectal perforation patients.

Keywords: biomarker; colorectal perforation; endotoxemia; endotoxin activity assay; severity.

MeSH terms

  • Biomarkers
  • Colorectal Neoplasms*
  • Endotoxins*
  • Hospitalization
  • Humans
  • Intensive Care Units

Substances

  • Endotoxins
  • Biomarkers